John Kilgour, Vice President of Acute

home / authors / john-kilgour-vice-president-of-acute

Articles

Uncovering Hidden Savings in the Hospital Pharmacy

Uncovering Hidden Savings in the Hospital Pharmacy

John Kilgour, Vice President of Acute;Alternate Care Sales for Specialty Pharmaceutical Distribution at Cardinal Health;Kathy Chase, PharmD, Director of Drug Cost Control Services at Cardinal Health
March 15th 2019

The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.

Read More

Latest Updated Articles

Non Small Cell Lung Cancer (NSCLC) in the lung tissue – closeup view 3d illustration
Published: September 9th 2024 | Updated: September 17th 2024
MARIPOSA Study Shows No Significant Differences Between Lazertinib and Osimertinib for NSCLC
Image Credit: ralwel - stock.adobe.com
Published: September 13th 2024 | Updated: September 17th 2024
FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis
Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com
Published: August 19th 2024 | Updated: September 17th 2024
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors
Image Credit: © Zhanna - stock.adobe.com
Published: September 4th 2024 | Updated: September 17th 2024
Insights Into Immunotherapies For Adults With TP53-Mutated Acute Lymphoblastic Leukemia
Image Credit: © Gefo- stock.adobe.com
Published: September 7th 2024 | Updated: September 17th 2024
Expanding Treatment Horizons for Sickle Cell Disease: Barriers, Innovations, and Future Directions
X-ray of breast cancer -- Image credit: peterschreiber.media | stock.adobe.com
Published: August 28th 2024 | Updated: September 17th 2024
Pharmacists Enhance Care for Patients With HR+/HER2– Breast Cancer on CDK4/6 Inhibitor Therapy